KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Other Accumulated Expenses (2016 - 2026)

Staar Surgical (STAA) has disclosed Other Accumulated Expenses for 17 consecutive years, with $40.9 million as the latest value for Q1 2026.

  • For the quarter ending Q1 2026, Other Accumulated Expenses fell 5.17% year-over-year to $40.9 million, compared with a TTM value of $40.9 million through Jan 2026, down 5.17%, and an annual FY2026 reading of $40.9 million, down 5.17% over the prior year.
  • Other Accumulated Expenses was $40.9 million for Q1 2026 at Staar Surgical, up from $39.6 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $47.7 million in Q1 2025 and bottomed at $589000.0 in Q2 2024.
  • Average Other Accumulated Expenses over 5 years is $19.8 million, with a median of $10.0 million recorded in 2023.
  • Peak annual rise in Other Accumulated Expenses hit 1761.21% in 2024, while the deepest fall reached 98.16% in 2024.
  • Year by year, Other Accumulated Expenses stood at $7.7 million in 2022, then tumbled by 70.07% to $2.3 million in 2023, then surged by 1761.21% to $43.1 million in 2024, then dropped by 8.05% to $39.6 million in 2025, then rose by 3.14% to $40.9 million in 2026.
  • Business Quant data shows Other Accumulated Expenses for STAA at $40.9 million in Q1 2026, $39.6 million in Q3 2025, and $1.1 million in Q2 2025.